World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4586)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

244

HTML

2729

Sum=2973

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

246

Download

643

Sum=889

Publishing Process of This Article

Item

Count

Browse

116

Download

432

Sum=548

May 21, 2024 (publication date) through Dec 19, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	de Mattos AZ, Bombassaro IZ, Vogel A, Debes JD. Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice. World J Gastroenterol 2024; 30(19): 2488-2495 [PMID: 38817660 DOI: 10.3748/wjg.v30.i19.2488]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i19/2488.htm

Number	Citing Articles
1	Rui-Nan Zhang, Jian-Gao Fan. Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma. World Journal of Gastroenterology 2024; 30(33): 3799-3802 doi: 10.3748/wjg.v30.i33.3799 Abstract(601) \| Core Tip(620) \| Full Article(HTML)(1936) \| Full Article with Cover (PDF)-1627K(122) \| Audio-372K(13) \| Peer-Review Report-216K(93) \| Answering Reviewers-90K(86) \| Full Article (PDF)-358K(136) \| Full Article (XML)-61K(94) \| Times Cited (1) \| Total Visits (4807) \| Open
2	Feng Gao, Xuefei Feng, Xinyu Li. Recent advances in polymeric nanoparticles for the treatment of hepatic diseases. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1528752
3	Zhouxia Wei, Yingxian Li, Suyan Jiang. Evaluation of the efficacy of laparoscopic hepatolobectomy for primary liver cancer with early combined enteral and parenteral nutritional support. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02851-2
4	Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875 Abstract(737) \| Core Tip(764) \| Full Article(HTML)(1567) \| Full Article with Cover (PDF)-639K(165) \| Audio-785K(15) \| Peer-Review Report-230K(94) \| Answering Reviewers-209K(101) \| Full Article (PDF)-410K(124) \| Full Article (XML)-117K(102) \| Times Cited (0) \| Total Visits (5254) \| Open
5	Soykan Agar. De novo Drug Design and Repurposing to Suppress Liver Cancer via VEGF-R1 Mechanism: Comprehensive Molecular Docking, Molecular Dynamics Simulations and ADME Estimation. Medicinal Chemistry 2025; 21(6): 501 doi: 10.2174/0115734064333811240928105309
6	Zheng-Wen Wang, Cai-Yan Pan, Cang-Long Wei, Hui Liao, Xiao-Po Zhang, Cai-Yun Zhang, Lei Yu. Oxocrebanine inhibits the proliferation of hepatocellular carcinoma cells by promoting apoptosis and autophagy. World Journal of Gastrointestinal Oncology 2025; 17(6): 105570 doi: 10.4251/wjgo.v17.i6.105570 Abstract(222) \| Core Tip(214) \| Full Article(HTML)(593) \| Full Article with Cover (PDF)-5761K(84) \| Audio-157K(11) \| Peer-Review Report-235K(45) \| Answering Reviewers-79K(49) \| Full Article (PDF)-5520K(80) \| Full Article (XML)-101K(49) \| Times Cited (0) \| Total Visits (2430) \| Open
7	Nguyen H. Tran, Scott A. Soefje, Nivedita Rangarajan, Purushotham Krishnappa, Tyler E. Wagner, Stephen J. Valerio, Rye Anderson, Jody C. Olson. Patient Characteristics, Treatment Patterns, and Outcomes in Unresectable Hepatocellular Carcinoma Treated with First-Line Systemic Therapy in the United States. Cancers 2025; 17(21): 3499 doi: 10.3390/cancers17213499